Consequences of COVID-19 on people with diabetes
Endocrinol Diabetes Nutr (Engl Ed). 2020 Jun-Jul;67(6):355-356.
doi: 10.1016/j.endinu.2020.04.001.
Epub 2020 May 11.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Endocrinología y Nutrición, Hospital Universitario Cruces, Biocruces, Universidad del País Vasco, Vizcaya, España. Electronic address: virginiabellido@gmail.com.
- 2 Servicio de Endocrinología y Nutrición, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Universitat Autònoma de Barcelona. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, España. Electronic address: aperez@santpau.cat.
No abstract available
MeSH terms
-
Antimalarials / therapeutic use
-
Betacoronavirus*
-
COVID-19
-
Coronavirus Infections / complications*
-
Coronavirus Infections / epidemiology
-
Diabetes Complications / complications*
-
Diabetes Complications / drug therapy
-
Health Services Accessibility
-
Hospitalization
-
Humans
-
Hydroxychloroquine / therapeutic use
-
Hyperglycemia / complications
-
Hyperglycemia / drug therapy
-
Hypoglycemic Agents / therapeutic use
-
Pandemics
-
Pneumonia, Viral / complications*
-
Pneumonia, Viral / epidemiology
-
Prognosis
-
Risk
-
SARS-CoV-2
Substances
-
Antimalarials
-
Hypoglycemic Agents
-
Hydroxychloroquine